S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:APTO

Aptose Biosciences News Headlines

$3.75
+0.04 (+1.08 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.39
Now: $3.75
$3.88
50-Day Range
$3.71
MA: $4.33
$4.69
52-Week Range
$3.39
Now: $3.75
$9.00
Volume2.17 million shs
Average Volume1.04 million shs
Market Capitalization$333.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

Aptose Biosciences (NASDAQ APTO) News Headlines Today

Source:
SourceHeadline
Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at JonestradingAptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at Jonestrading
marketbeat.com - February 22 at 8:23 AM
These 2 Penny Stocks Are Well Positioned for Gains, Say AnalystsThese 2 Penny Stocks Are Well Positioned for Gains, Say Analysts
nasdaq.com - March 5 at 3:39 AM
Aptose Biosciences (NASDAQ:APTO) Trading Down 5.8%Aptose Biosciences (NASDAQ:APTO) Trading Down 5.8%
americanbankingnews.com - March 4 at 7:16 PM
Aptose Biosciences (NASDAQ:APTO) Now Covered by JonestradingAptose Biosciences (NASDAQ:APTO) Now Covered by Jonestrading
americanbankingnews.com - February 22 at 8:59 AM
Aptose Biosciences (NASDAQ:APTO) Trading Down 6.2%Aptose Biosciences (NASDAQ:APTO) Trading Down 6.2%
americanbankingnews.com - February 18 at 7:46 PM
-$0.16 Earnings Per Share Expected for Aptose Biosciences Inc. (NASDAQ:APTO) This Quarter-$0.16 Earnings Per Share Expected for Aptose Biosciences Inc. (NASDAQ:APTO) This Quarter
americanbankingnews.com - February 12 at 3:16 AM
Were Hopeful That Aptose Biosciences (TSE:APS) Will Use Its Cash WiselyWe're Hopeful That Aptose Biosciences (TSE:APS) Will Use Its Cash Wisely
finance.yahoo.com - February 3 at 7:45 AM
ACT NOW: 1 Pharma Stock That Could Triple in ValueACT NOW: 1 Pharma Stock That Could Triple in Value
fool.ca - February 1 at 8:19 AM
Aptose Biosciences (APTO) Sees Hammer Chart Pattern: Time to Buy?Aptose Biosciences (APTO) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - December 30 at 8:55 AM
Is APTO A Good Stock To Buy Now According To Hedge Funds?Is APTO A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 18 at 10:44 PM
Athenex (ATNX) Gets FDA Approval for Skin Treatment KlisyriAthenex (ATNX) Gets FDA Approval for Skin Treatment Klisyri
finance.yahoo.com - December 16 at 12:30 PM
Bristol Myers (BMY) Gets Positive CHMP Opinion for InrebicBristol Myers (BMY) Gets Positive CHMP Opinion for Inrebic
finance.yahoo.com - December 14 at 1:42 PM
Aptose Shares Sell Off As The Market Wanted More Than Further Signs And PortentsAptose Shares Sell Off As The Market Wanted More Than Further Signs And Portents
seekingalpha.com - December 8 at 4:25 PM
Strength Seen in Aptose (APTO): Stock Soars 5.3%Strength Seen in Aptose (APTO): Stock Soars 5.3%
finance.yahoo.com - December 2 at 1:16 PM
2 Biotech Stocks That Could Double Your Money2 Biotech Stocks That Could Double Your Money
finance.yahoo.com - November 17 at 12:40 PM
Aptose Shares Look Undervalued Ahead Of Value-Driving Efficacy DataAptose Shares Look Undervalued Ahead Of Value-Driving Efficacy Data
seekingalpha.com - November 12 at 8:24 AM
Aptose Biosciences (APTO) CEO William Rice on Q3 2020 Results - Earnings Call TranscriptAptose Biosciences' (APTO) CEO William Rice on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:46 AM
Aptose Reports Results for the Third Quarter 2020Aptose Reports Results for the Third Quarter 2020
finance.yahoo.com - November 10 at 7:06 PM
Is Aptose Biosciences Inc.s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?Is Aptose Biosciences Inc.'s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - November 5 at 8:52 AM
Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020
finance.yahoo.com - October 27 at 7:21 PM
Aptose Biosciences, Inc. Rings the Nasdaq Stock Market Closing BellAptose Biosciences, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - October 19 at 10:21 PM
Aptose initiates dosing of CG-806 for acute myeloid leukemiaAptose initiates dosing of CG-806 for acute myeloid leukemia
seekingalpha.com - October 19 at 12:19 PM
Aptose Biosciences, Inc. Rings the Closing BellAptose Biosciences, Inc. Rings the Closing Bell
nasdaq.com - October 19 at 12:19 PM
Aptose to Present at September Investor ConferencesAptose to Present at September Investor Conferences
finance.yahoo.com - September 9 at 8:26 AM
Aptose Biosciences (APTO) Surges: Stock Moves 9.8% HigherAptose Biosciences (APTO) Surges: Stock Moves 9.8% Higher
finance.yahoo.com - September 2 at 12:50 PM
RBC: These 2 Stocks Are Poised to Surge by at Least 80%RBC: These 2 Stocks Are Poised to Surge by at Least 80%
finance.yahoo.com - August 26 at 1:11 PM
Aptose Biosciences: Validation Impending For This Targeted Oncology PlayerAptose Biosciences: Validation Impending For This Targeted Oncology Player
seekingalpha.com - August 24 at 6:34 PM
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth ConferenceAptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference
finance.yahoo.com - August 14 at 1:24 AM
Aptose Reports Results for the Second Quarter 2020Aptose Reports Results for the Second Quarter 2020
finance.yahoo.com - August 4 at 5:48 PM
Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020
finance.yahoo.com - July 21 at 5:46 PM
Aptose prices equity offering at $5.25Aptose prices equity offering at $5.25
seekingalpha.com - July 16 at 4:09 AM
BRIEF-Aptose Announces FDA Allowance Of IND For Phase 1A/B Study Of Cg-806 In Acute Myeloid LeukemiaBRIEF-Aptose Announces FDA Allowance Of IND For Phase 1A/B Study Of Cg-806 In Acute Myeloid Leukemia
www.reuters.com - June 29 at 7:44 PM
Aptose to launch early-stage CG-806 study in acute myeloid leukemiaAptose to launch early-stage CG-806 study in acute myeloid leukemia
seekingalpha.com - June 29 at 9:38 AM
Thinking about trading options or stock in Aptose Biosciences, Novavax, Inovio Pharmaceuticals, Ford Motor, or Carnival Corp?Thinking about trading options or stock in Aptose Biosciences, Novavax, Inovio Pharmaceuticals, Ford Motor, or Carnival Corp?
www.prnewswire.com - June 29 at 9:38 AM
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid LeukemiaAptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia
finance.yahoo.com - June 29 at 9:38 AM
Is Aptose Biosciences Inc (APTO) A Good Stock To Buy?Is Aptose Biosciences Inc (APTO) A Good Stock To Buy?
finance.yahoo.com - June 28 at 12:21 AM
3 “Perfect 10” Stocks Under $10 With Big Upside Potential3 “Perfect 10” Stocks Under $10 With Big Upside Potential
finance.yahoo.com - June 23 at 12:52 PM
Aptoses CG-806 shows encouraging effect in blood cancerAptose's CG-806 shows encouraging effect in blood cancer
seekingalpha.com - June 12 at 12:55 PM
Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology AssociationAptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association
finance.yahoo.com - June 12 at 7:55 AM
Aptose Biosciences EPS misses by $0.05Aptose Biosciences EPS misses by $0.05
seekingalpha.com - May 5 at 4:57 PM
Aptose Biosciences (APTO) PR\resents At 2020 Virtual Annual Meeting Of AACR - SlideshowAptose Biosciences (APTO) PR\resents At 2020 Virtual Annual Meeting Of AACR - Slideshow
seekingalpha.com - April 29 at 6:29 PM
BRIEF-Aptose Presents Preliminary Clinical Data On CG-806BRIEF-Aptose Presents Preliminary Clinical Data On CG-806
www.reuters.com - April 28 at 12:54 AM
Why Aptose Biosciences Stock Sank TodayWhy Aptose Biosciences Stock Sank Today
finance.yahoo.com - April 27 at 7:53 PM
CG-806 data fails to lift Aptose, down 11%CG-806 data fails to lift Aptose, down 11%
seekingalpha.com - April 27 at 2:53 PM
Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020
finance.yahoo.com - April 27 at 9:52 AM
Aptose Biosciences Files Proxy Statement, Announces Online Only Annual General MeetingAptose Biosciences Files Proxy Statement, Announces Online Only Annual General Meeting
finance.yahoo.com - April 24 at 8:26 AM
Aptose to Release First Quarter Ended March 31, 2020 Financial Results and Hold Conference Call on May 5, 2020Aptose to Release First Quarter Ended March 31, 2020 Financial Results and Hold Conference Call on May 5, 2020
finance.yahoo.com - April 21 at 8:44 AM
Bromodomain Containing Protein 4 Market Future Investment and Forecast 2029 | Aptose Biosciences Inc and Arvinas IncBromodomain Containing Protein 4 Market Future Investment and Forecast 2029 | Aptose Biosciences Inc and Arvinas Inc
www.marketwatch.com - March 23 at 9:34 AM
BRIEF-Aptose Posts Quarterly Net Loss Of $7.7 MillionBRIEF-Aptose Posts Quarterly Net Loss Of $7.7 Million
www.reuters.com - March 10 at 6:44 PM
Aptose Biosciences, Inc. to Host Earnings CallAptose Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 10 at 6:44 PM
Aptose Reports Results for the Fourth Quarter and Full Year 2019Aptose Reports Results for the Fourth Quarter and Full Year 2019
finance.yahoo.com - March 10 at 6:44 PM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.